TWiV 767: COVID-19 clinical update #66 with Dr. Daniel Griffin
About this episode
In COVID-19 clinical update #66, Daniel Griffin covers treatment guidelines from IDSA, hospitalization of adolescents, estimating epidemiological dynamics from viral load distributions, incidence of infection according to baseline antibody status, assessment of reinfection in Italy, need for vaccination in previously infected individuals, assessment of protection against reinfection, antimicrobial use in hospitalized patients, effect of single dose ivermectin, and a trial of aspirin in hospitalized patients.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- COVID-19 treatment guidelines (IDSA)
- Hospitalization of adolescents (MMWR)
- Estimating dynamics from viral load (Science)
- Incidence according to antibody status (Lancet)
- Reinfections in Italy (JAMA)
- Need for vaccination in previously infected (medRxiv)
- Assessment of protection against reinfection (ACC)
- Antimicrobial use in hospitalized patients (Lancet)
- Effect of single dose ivermectin (Viruses)
- Aspirin in hospitalized patients (medRxiv)
- Letters read on TWiV 767
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology